240 related articles for article (PubMed ID: 37132587)
1. Ferroptosis-Enhanced Immunotherapy with an Injectable Dextran-Chitosan Hydrogel for the Treatment of Malignant Ascites in Hepatocellular Carcinoma.
Meng J; Yang X; Huang J; Tuo Z; Hu Y; Liao Z; Tian Y; Deng S; Deng Y; Zhou Z; Lovell JF; Jin H; Liu Y; Yang K
Adv Sci (Weinh); 2023 Jul; 10(20):e2300517. PubMed ID: 37132587
[TBL] [Abstract][Full Text] [Related]
2. Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel.
Dai X; Meng J; Deng S; Zhang L; Wan C; Lu L; Huang J; Hu Y; Zhang Z; Li Y; Lovell JF; Wu G; Yang K; Jin H
Theranostics; 2020; 10(7):3049-3063. PubMed ID: 32194854
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of thermosensitive Pluronic hydrogel for codelivery of resveratrol microspheres and cisplatin in the treatment of liver cancer ascites.
Wen Q; Zhang Y; Luo J; Xiong K; Lu Y; Wu Z; Wang BQ; Wu J; Chen Y; Fu S
Int J Pharm; 2020 May; 582():119334. PubMed ID: 32305362
[TBL] [Abstract][Full Text] [Related]
4. Folic Acid-Modified Long-Circulating Liposomes Loaded with Sulfasalazine For Targeted Induction of Ferroptosis in Melanoma.
Zhang D; Zhang M; Pang Y; Li M; Ma W
ACS Biomater Sci Eng; 2024 Jan; 10(1):588-598. PubMed ID: 38117929
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal administration of thermosensitive hydrogel Co-loaded with norcantharidin nanoparticles and oxaliplatin inhibits malignant ascites of hepatocellular carcinoma.
Xiao S; Wang Y; Ma W; Zhou P; Wang B; Wu Z; Wen Q; Xiong K; Liu Y; Fu S
Drug Deliv; 2022 Dec; 29(1):2713-2722. PubMed ID: 35975331
[TBL] [Abstract][Full Text] [Related]
6. Mucoadhesive chitosan hydrogels as rectal drug delivery vessels to treat ulcerative colitis.
Xu J; Tam M; Samaei S; Lerouge S; Barralet J; Stevenson MM; Cerruti M
Acta Biomater; 2017 Jan; 48():247-257. PubMed ID: 27769943
[TBL] [Abstract][Full Text] [Related]
7. PGAM1 Inhibition Promotes HCC Ferroptosis and Synergizes with Anti-PD-1 Immunotherapy.
Zheng Y; Wang Y; Lu Z; Wan J; Jiang L; Song D; Wei C; Gao C; Shi G; Zhou J; Fan J; Ke A; Zhou L; Cai J
Adv Sci (Weinh); 2023 Oct; 10(29):e2301928. PubMed ID: 37705495
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer.
Cheu JW; Lee D; Li Q; Goh CC; Bao MH; Yuen VW; Zhang MS; Yang C; Chan CY; Tse AP; Sit GF; Liu CX; Ng IO; Wong CM; Wong CC
Cell Mol Gastroenterol Hepatol; 2023; 16(1):133-159. PubMed ID: 36893885
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing.
Hao X; Zheng Z; Liu H; Zhang Y; Kang J; Kong X; Rong D; Sun G; Sun G; Liu L; Yu H; Tang W; Wang X
Redox Biol; 2022 Oct; 56():102463. PubMed ID: 36108528
[TBL] [Abstract][Full Text] [Related]
10. Antitumor and antimetastasis effects of macerating solutions from an injectable chitosan-based hydrogel on hepatocarcinoma.
Wang H; Song F; Chen Q; Hu R; Jiang Z; Yang Y; Han B
J Biomed Mater Res A; 2015 Dec; 103(12):3879-85. PubMed ID: 26123792
[TBL] [Abstract][Full Text] [Related]
11. Supramolecular Polymer-Nanomedicine Hydrogel Loaded with Tumor Associated Macrophage-Reprogramming polyTLR7/8a Nanoregulator for Enhanced Anti-Angiogenesis Therapy of Orthotopic Hepatocellular Carcinoma.
Liu X; Huangfu Y; Wang J; Kong P; Tian W; Liu P; Fang C; Li S; Nie Y; Feng Z; Huang P; Shi S; Zhang C; Dong A; Wang W
Adv Sci (Weinh); 2023 Aug; 10(22):e2300637. PubMed ID: 37229748
[TBL] [Abstract][Full Text] [Related]
12. 3,6-Epidioxy-1,10-bisaboladiene and sulfasalazine synergistically induce ferroptosis-like cell death in human breast cancer cell lines.
Usukhbayar N; Uesugi S; Kimura KI
Biosci Biotechnol Biochem; 2023 Oct; 87(11):1336-1344. PubMed ID: 37604790
[TBL] [Abstract][Full Text] [Related]
13. Piperlongumine rapidly induces the death of human pancreatic cancer cells mainly through the induction of ferroptosis.
Yamaguchi Y; Kasukabe T; Kumakura S
Int J Oncol; 2018 Mar; 52(3):1011-1022. PubMed ID: 29393418
[TBL] [Abstract][Full Text] [Related]
14. Targeting ferroptosis in hepatocellular carcinoma.
Mo Y; Zou Z; Chen E
Hepatol Int; 2024 Feb; 18(1):32-49. PubMed ID: 37880567
[TBL] [Abstract][Full Text] [Related]
15. Injectable microenvironment-responsive hydrogels with redox-activatable supramolecular prodrugs mediate ferroptosis-immunotherapy for postoperative tumor treatment.
Cheng Z; Xue C; Liu M; Cheng Z; Tian G; Li M; Xue R; Yao X; Zhang Y; Luo Z
Acta Biomater; 2023 Oct; 169():289-305. PubMed ID: 37544392
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Chemo-Immunotherapy Strategy Utilizing Injectable Thermosensitive Hydrogel for The Treatment of Diffuse Peritoneal Metastasis in Advanced Colorectal Cancer.
Wang M; Hu D; Yang Y; Shi K; Li J; Liu Q; Li Y; Li R; Pan M; Mo D; Chen W; Li X; Qian Z
Adv Sci (Weinh); 2023 Dec; 10(35):e2303819. PubMed ID: 37875399
[TBL] [Abstract][Full Text] [Related]
17. [Antineoplastic effect of hydrogel prospidin on Seidel ascites hepatoma used as a model].
Bychkovskiĭ PM; Iurkshtovich TL; Kladiev AA; Revtovich MIu
Tsitologiia; 2012; 54(3):230-5. PubMed ID: 22645987
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumor immunity and ferroptosis of hepatocellular carcinoma are enhanced by combined therapy of sorafenib and delivering modified GO-based PD-L1 siRNAs.
Li Z; Bu J; Zhu X; Zhou H; Ren K; Chu PK; Li L; Hu X; Ding X
Biomater Adv; 2022 May; 136():212761. PubMed ID: 35929305
[TBL] [Abstract][Full Text] [Related]
19. Injectable Hyaluronic Acid Hydrogel for the Co-Delivery of Gemcitabine Nanoparticles and Cisplatin for Malignant Ascites Therapy.
Wang J; Leng Q; Li Y; Wen Q; Luo J; Wang B; Lu Y; Wu Z; Xiong K; Fu S
J Biomed Nanotechnol; 2020 Dec; 16(12):1727-1739. PubMed ID: 33485400
[TBL] [Abstract][Full Text] [Related]
20. pH-responsive self-healing injectable hydrogel based on N-carboxyethyl chitosan for hepatocellular carcinoma therapy.
Qu J; Zhao X; Ma PX; Guo B
Acta Biomater; 2017 Aug; 58():168-180. PubMed ID: 28583902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
